|
Xilong Scientific Co., Ltd. (002584.SZ) Évaluation DCF
CN | Basic Materials | Chemicals | SHZ
|
- ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
- ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
- ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
- ✓ Aucune Expertise N'Est Requise; Facile À Suivre
Xilong Scientific Co., Ltd. (002584.SZ) Bundle
Optimisez votre temps et améliorez la précision avec notre calculatrice DCF (002584SZ)! En utilisant des données réelles de Xilong Scientific Co., Ltd. et des hypothèses personnalisables, cet outil vous permet de prévoir, analyser et valoriser le Scientifique Xilong comme un investisseur chevronné.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3,337.7 | 6,243.2 | 6,837.7 | 6,183.2 | 7,693.2 | 9,836.3 | 12,576.3 | 16,079.6 | 20,558.8 | 26,285.6 |
| Revenue Growth, % | 0 | 87.05 | 9.52 | -9.57 | 24.42 | 27.86 | 27.86 | 27.86 | 27.86 | 27.86 |
| EBITDA | 149.7 | 187.4 | 322.0 | 219.6 | 153.1 | 348.9 | 446.1 | 570.4 | 729.3 | 932.4 |
| EBITDA, % | 4.49 | 3 | 4.71 | 3.55 | 1.99 | 3.55 | 3.55 | 3.55 | 3.55 | 3.55 |
| Depreciation | 39.7 | 34.4 | 37.4 | 47.8 | 49.3 | 72.8 | 93.1 | 119.1 | 152.3 | 194.7 |
| Depreciation, % | 1.19 | 0.55176 | 0.54652 | 0.77302 | 0.64081 | 0.74057 | 0.74057 | 0.74057 | 0.74057 | 0.74057 |
| EBIT | 110.0 | 152.9 | 284.6 | 171.8 | 103.8 | 276.1 | 353.0 | 451.3 | 577.0 | 737.8 |
| EBIT, % | 3.29 | 2.45 | 4.16 | 2.78 | 1.35 | 2.81 | 2.81 | 2.81 | 2.81 | 2.81 |
| Total Cash | 1,217.4 | 877.8 | 949.9 | 990.7 | 559.9 | 1,725.8 | 2,206.5 | 2,821.2 | 3,607.0 | 4,611.8 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 615.1 | 1,271.0 | 1,188.6 | 1,449.7 | 1,636.9 | 1,984.8 | 2,537.7 | 3,244.6 | 4,148.5 | 5,304.1 |
| Account Receivables, % | 18.43 | 20.36 | 17.38 | 23.45 | 21.28 | 20.18 | 20.18 | 20.18 | 20.18 | 20.18 |
| Inventories | 395.3 | 713.3 | 454.4 | 508.2 | 561.7 | 893.8 | 1,142.8 | 1,461.1 | 1,868.1 | 2,388.5 |
| Inventories, % | 11.84 | 11.43 | 6.65 | 8.22 | 7.3 | 9.09 | 9.09 | 9.09 | 9.09 | 9.09 |
| Accounts Payable | 752.2 | 1,046.1 | 1,278.0 | 1,178.1 | 950.3 | 1,758.5 | 2,248.4 | 2,874.7 | 3,675.5 | 4,699.3 |
| Accounts Payable, % | 22.54 | 16.76 | 18.69 | 19.05 | 12.35 | 17.88 | 17.88 | 17.88 | 17.88 | 17.88 |
| Capital Expenditure | -9.8 | -38.2 | -56.7 | -323.7 | -215.2 | -192.2 | -245.7 | -314.2 | -401.7 | -513.6 |
| Capital Expenditure, % | -0.2938 | -0.61258 | -0.82962 | -5.24 | -2.8 | -1.95 | -1.95 | -1.95 | -1.95 | -1.95 |
| Tax Rate, % | 22.31 | 22.31 | 22.31 | 22.31 | 22.31 | 22.31 | 22.31 | 22.31 | 22.31 | 22.31 |
| EBITAT | 91.7 | 109.5 | 234.3 | 148.9 | 80.6 | 221.8 | 283.6 | 362.6 | 463.6 | 592.8 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -136.5 | -574.4 | 788.1 | -541.8 | -553.8 | 230.7 | -181.0 | -231.4 | -295.9 | -378.3 |
| WACC, % | 6.66 | 6.5 | 6.64 | 6.71 | 6.58 | 6.62 | 6.62 | 6.62 | 6.62 | 6.62 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -637.4 | |||||||||
| Long Term Growth Rate, % | 3.00 | |||||||||
| Free cash flow (T + 1) | -390 | |||||||||
| Terminal Value | -10,773 | |||||||||
| Present Terminal Value | -7,820 | |||||||||
| Enterprise Value | -8,457 | |||||||||
| Net Debt | 450 | |||||||||
| Equity Value | -8,907 | |||||||||
| Diluted Shares Outstanding, MM | 556 | |||||||||
| Equity Value Per Share | -16.03 |
Benefits You Will Receive
- Adjustable Forecast Parameters: Easily modify key assumptions (growth %, margins, WACC) to explore various scenarios.
- Comprehensive Market Data: Financial information for Xilong Scientific Co., Ltd. (002584SZ) pre-filled to enhance your analysis.
- Automated DCF Calculations: The template generates Net Present Value (NPV) and intrinsic value calculations automatically.
- Versatile and Professional Design: A sleek Excel model tailored to meet your valuation requirements.
- Designed for Analysts and Investors: Perfect for evaluating projections, confirming strategies, and improving efficiency.
Key Features
- Comprehensive Data: Xilong Scientific’s historical financial records and pre-filled projections.
- Customizable Inputs: Adjust WACC, tax rates, revenue growth, and EBITDA margins to suit your analysis.
- Real-Time Insights: Instantly view Xilong Scientific’s intrinsic value recalculating as you make changes.
- Visual Analytics: Dashboard charts present valuation outcomes and essential metrics clearly.
- Precision Engineered: A sophisticated tool tailored for analysts, investors, and financial professionals.
How It Operates
- 1. Access the Template: Download and open the Excel file featuring Xilong Scientific Co., Ltd.'s (002584SZ) preloaded data.
- 2. Modify Assumptions: Adjust key parameters such as growth projections, WACC, and capital expenditures.
- 3. View Results in Real-Time: The DCF model automatically computes intrinsic value and NPV based on your inputs.
- 4. Experiment with Scenarios: Evaluate various forecasts to explore different valuation results.
- 5. Present with Assurance: Share professional valuation analyses to enhance your decision-making.
Why Opt for This Calculator?
- User-Friendly: Tailored for both novices and seasoned users.
- Customizable Inputs: Effortlessly adjust parameters to suit your analysis.
- Real-Time Updates: Observe immediate effects on Xilong Scientific's valuation as you modify inputs.
- Preloaded Data: Comes with Xilong Scientific's actual financial metrics for swift evaluations.
- Preferred by Experts: Utilized by investors and analysts for insightful decision-making.
Who Should Utilize Xilong Scientific's Offerings?
- Investors: Make informed choices with our advanced valuation tools tailored for precision.
- Financial Analysts: Enhance efficiency with our ready-to-customize DCF model designed for quick analysis.
- Consultants: Effortlessly modify our templates for impactful client presentations and reports.
- Finance Enthusiasts: Expand your knowledge of valuation methods through practical, real-world case studies.
- Educators and Students: Leverage our resources as a hands-on learning aid in finance courses.
Overview of Template Components
- Historical Data: Contains Xilong Scientific's previous financial performance and foundational forecasts.
- DCF and Levered DCF Models: Comprehensive templates designed to determine the intrinsic value of Xilong Scientific (002584SZ).
- WACC Sheet: Pre-configured calculations for the Weighted Average Cost of Capital.
- Editable Inputs: Update key factors such as growth rates, EBITDA percentages, and CAPEX projections.
- Quarterly and Annual Statements: A thorough analysis of Xilong Scientific's financial documents.
- Interactive Dashboard: Visualize valuation outcomes and projections in an engaging manner.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.